The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Percutaneous Coronary Intervention-Global Market Insights and Sales Trends 2024
Synopsis
Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualize the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open.
The global Percutaneous Coronary Intervention market size is expected to reach US$ 14990 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Percutaneous Coronary Intervention in various end use industries. The expanding demands from the Hospitals, Healthcare Centers and ASCs,, are propelling Percutaneous Coronary Intervention market. Coronary Stents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PTCA Catheters segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Percutaneous Coronary Intervention, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Percutaneous Coronary Intervention market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Percutaneous Coronary Intervention market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Percutaneous Coronary Intervention sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Percutaneous Coronary Intervention covered in this report include Abbott Vascular, Svelte Medical, Medtronic, Boston Scientific, Cordis, Terumo Medical, Amg International, Asahi Intecc and B. Braun, etc.
The global Percutaneous Coronary Intervention market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Vascular
Svelte Medical
Medtronic
Boston Scientific
Cordis
Terumo Medical
Amg International
Asahi Intecc
B. Braun
Global Percutaneous Coronary Intervention market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Percutaneous Coronary Intervention market, Segment by Type:
Coronary Stents
PTCA Catheters
Coronary Guidewires
Embolic Protection Devices
Global Percutaneous Coronary Intervention market, by Application
Hospitals
Healthcare Centers
ASCs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Percutaneous Coronary Intervention companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualize the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open.
The global Percutaneous Coronary Intervention market size is expected to reach US$ 14990 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Percutaneous Coronary Intervention in various end use industries. The expanding demands from the Hospitals, Healthcare Centers and ASCs,, are propelling Percutaneous Coronary Intervention market. Coronary Stents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PTCA Catheters segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Percutaneous Coronary Intervention, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Percutaneous Coronary Intervention market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Percutaneous Coronary Intervention market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Percutaneous Coronary Intervention sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Percutaneous Coronary Intervention covered in this report include Abbott Vascular, Svelte Medical, Medtronic, Boston Scientific, Cordis, Terumo Medical, Amg International, Asahi Intecc and B. Braun, etc.
The global Percutaneous Coronary Intervention market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Vascular
Svelte Medical
Medtronic
Boston Scientific
Cordis
Terumo Medical
Amg International
Asahi Intecc
B. Braun
Global Percutaneous Coronary Intervention market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Percutaneous Coronary Intervention market, Segment by Type:
Coronary Stents
PTCA Catheters
Coronary Guidewires
Embolic Protection Devices
Global Percutaneous Coronary Intervention market, by Application
Hospitals
Healthcare Centers
ASCs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Percutaneous Coronary Intervention companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Percutaneous Coronary Intervention
1.1 Percutaneous Coronary Intervention Market Overview
1.1.1 Percutaneous Coronary Intervention Product Scope
1.1.2 Percutaneous Coronary Intervention Market Status and Outlook
1.2 Global Percutaneous Coronary Intervention Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Percutaneous Coronary Intervention Market Size by Region (2018-2029)
1.4 Global Percutaneous Coronary Intervention Historic Market Size by Region (2018-2023)
1.5 Global Percutaneous Coronary Intervention Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Percutaneous Coronary Intervention Market Size (2018-2029)
1.6.1 North America Percutaneous Coronary Intervention Market Size (2018-2029)
1.6.2 Europe Percutaneous Coronary Intervention Market Size (2018-2029)
1.6.3 Asia-Pacific Percutaneous Coronary Intervention Market Size (2018-2029)
1.6.4 Latin America Percutaneous Coronary Intervention Market Size (2018-2029)
1.6.5 Middle East & Africa Percutaneous Coronary Intervention Market Size (2018-2029)
2 Percutaneous Coronary Intervention Market by Type
2.1 Introduction
2.1.1 Coronary Stents
2.1.2 PTCA Catheters
2.1.3 Coronary Guidewires
2.1.4 Embolic Protection Devices
2.2 Global Percutaneous Coronary Intervention Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Percutaneous Coronary Intervention Historic Market Size by Type (2018-2023)
2.2.2 Global Percutaneous Coronary Intervention Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Percutaneous Coronary Intervention Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Percutaneous Coronary Intervention Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Percutaneous Coronary Intervention Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Percutaneous Coronary Intervention Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Percutaneous Coronary Intervention Revenue Breakdown by Type (2018-2029)
3 Percutaneous Coronary Intervention Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Healthcare Centers
3.1.3 ASCs
3.2 Global Percutaneous Coronary Intervention Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Percutaneous Coronary Intervention Historic Market Size by Application (2018-2023)
3.2.2 Global Percutaneous Coronary Intervention Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Percutaneous Coronary Intervention Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Percutaneous Coronary Intervention Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Percutaneous Coronary Intervention Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Percutaneous Coronary Intervention Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Percutaneous Coronary Intervention Revenue Breakdown by Application (2018-2029)
4 Percutaneous Coronary Intervention Competition Analysis by Players
4.1 Global Percutaneous Coronary Intervention Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Percutaneous Coronary Intervention as of 2022)
4.3 Date of Key Players Enter into Percutaneous Coronary Intervention Market
4.4 Global Top Players Percutaneous Coronary Intervention Headquarters and Area Served
4.5 Key Players Percutaneous Coronary Intervention Product Solution and Service
4.6 Competitive Status
4.6.1 Percutaneous Coronary Intervention Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Vascular
5.1.1 Abbott Vascular Profile
5.1.2 Abbott Vascular Main Business
5.1.3 Abbott Vascular Percutaneous Coronary Intervention Products, Services and Solutions
5.1.4 Abbott Vascular Percutaneous Coronary Intervention Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Vascular Recent Developments
5.2 Svelte Medical
5.2.1 Svelte Medical Profile
5.2.2 Svelte Medical Main Business
5.2.3 Svelte Medical Percutaneous Coronary Intervention Products, Services and Solutions
5.2.4 Svelte Medical Percutaneous Coronary Intervention Revenue (US$ Million) & (2018-2023)
5.2.5 Svelte Medical Recent Developments
5.3 Medtronic
5.3.1 Medtronic Profile
5.3.2 Medtronic Main Business
5.3.3 Medtronic Percutaneous Coronary Intervention Products, Services and Solutions
5.3.4 Medtronic Percutaneous Coronary Intervention Revenue (US$ Million) & (2018-2023)
5.3.5 Boston Scientific Recent Developments
5.4 Boston Scientific
5.4.1 Boston Scientific Profile
5.4.2 Boston Scientific Main Business
5.4.3 Boston Scientific Percutaneous Coronary Intervention Products, Services and Solutions
5.4.4 Boston Scientific Percutaneous Coronary Intervention Revenue (US$ Million) & (2018-2023)
5.4.5 Boston Scientific Recent Developments
5.5 Cordis
5.5.1 Cordis Profile
5.5.2 Cordis Main Business
5.5.3 Cordis Percutaneous Coronary Intervention Products, Services and Solutions
5.5.4 Cordis Percutaneous Coronary Intervention Revenue (US$ Million) & (2018-2023)
5.5.5 Cordis Recent Developments
5.6 Terumo Medical
5.6.1 Terumo Medical Profile
5.6.2 Terumo Medical Main Business
5.6.3 Terumo Medical Percutaneous Coronary Intervention Products, Services and Solutions
5.6.4 Terumo Medical Percutaneous Coronary Intervention Revenue (US$ Million) & (2018-2023)
5.6.5 Terumo Medical Recent Developments
5.7 Amg International
5.7.1 Amg International Profile
5.7.2 Amg International Main Business
5.7.3 Amg International Percutaneous Coronary Intervention Products, Services and Solutions
5.7.4 Amg International Percutaneous Coronary Intervention Revenue (US$ Million) & (2018-2023)
5.7.5 Amg International Recent Developments
5.8 Asahi Intecc
5.8.1 Asahi Intecc Profile
5.8.2 Asahi Intecc Main Business
5.8.3 Asahi Intecc Percutaneous Coronary Intervention Products, Services and Solutions
5.8.4 Asahi Intecc Percutaneous Coronary Intervention Revenue (US$ Million) & (2018-2023)
5.8.5 Asahi Intecc Recent Developments
5.9 B. Braun
5.9.1 B. Braun Profile
5.9.2 B. Braun Main Business
5.9.3 B. Braun Percutaneous Coronary Intervention Products, Services and Solutions
5.9.4 B. Braun Percutaneous Coronary Intervention Revenue (US$ Million) & (2018-2023)
5.9.5 B. Braun Recent Developments
6 North America
6.1 North America Percutaneous Coronary Intervention Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Percutaneous Coronary Intervention Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Percutaneous Coronary Intervention Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Percutaneous Coronary Intervention Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Percutaneous Coronary Intervention Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Percutaneous Coronary Intervention Market Dynamics
11.1 Percutaneous Coronary Intervention Industry Trends
11.2 Percutaneous Coronary Intervention Market Drivers
11.3 Percutaneous Coronary Intervention Market Challenges
11.4 Percutaneous Coronary Intervention Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
